Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 11, 2018 - Issue 5
Submit an article Journal homepage
742
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response to: Pharmacological treatment of primary membranous nephropathy in 2016

Nikoleta Printza1st Pediatric Department, Aristotle University, Thessaloniki, GreeceCorrespondence[email protected]
View further author information
,
Ireni Georeli1st Pediatric Department, Aristotle University, Thessaloniki, GreeceView further author information
,
Stella Stabouli1st Pediatric Department, Aristotle University, Thessaloniki, GreeceView further author information
,
John Dotis1st Pediatric Department, Aristotle University, Thessaloniki, GreeceView further author information
,
Christina Sidira1st Pediatric Department, Aristotle University, Thessaloniki, GreeceView further author information
&
Fotios Papachristou1st Pediatric Department, Aristotle University, Thessaloniki, GreeceView further author information
Pages 459-461 | Published online: 25 Apr 2018

References

  • Van de Logt AE, Hofstra JM, Wetzels JF. Pharmacological treatment of primary membranous nephropathy in 2016. Expert Rev Clin Pharmacol. 2016 Sep;16:1–16.
  • Ayalon R, Beck LH Jr. Membranous nephropathy: not just a disease for adults. Pediatr Nephrol. 2015 Jan;30(1):31–39.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:139–274.
  • Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009 Jul 2;361(1):11–21.
  • Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994 Jan 15;83(2):435–445.
  • Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines – application to the individual patient. Kidney Int. 2012 Oct;82(8):840–856.
  • Menon S, Valentini RP. Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol. 2010 Aug;25(8):1419–1428.
  • Moxey-Mims MM, Stapleton FB, Feld LG. Applying decision analysis to management of adolescent idiopathic nephrotic syndrome. Pediatr Nephrol. 1994 Dec;8(6):660–664.
  • Cameron JS. Membranous nephropathy in childhood and its treatment. Pediatr Nephrol. 1990 Mar;4(2):193–198.
  • US Renal Data System. US Renal Data System, USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2012
  • Cravedi P, Sghirlanzoni MC, Marasà M, et al. Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study. Am J Nephrol. 2011;33(5):461–468.
  • Remuzzi G, Chiurchiu C, Abbate M, et al. Rituximab for idiopathic membranous nephropathy. Lancet. 2002 Sep 21;360(9337):923–924.
  • Dahan K, Debiec H, Plaisier E, et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J Am Soc Nephrol. 2017 Jan;28(1):348–358.
  • Fervenza FC, Cosio FG, Erickson SB, et al. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int. 2008 Jan;73(1):117–125.
  • Mallat SG, Itani HS, Abou-Mrad RM, et al. Rituximab use in adult primary glomerulopathy: where is the evidence? Ther Clin Risk Manag. 2016 Aug 29;12:1317–1327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.